ACADIA Pharmaceuticals Inc. (ACAD)
Biotechnology · Healthcare · $3.7B
Intrinsic Value (Consensus)
$34.62
Current Price
$21.64
Margin of Safety
+60%
60% Below Intrinsic Value
Value: $35
Price: $22
Valuation Model Estimates
Current Price: $21.64
DCF (Discounted Cash Flow)
$64.26
Graham Number
$18.79
Earnings Power Value
$23.13
Relative Value (P/E)
$32.29
Dividend Discount Model
Not applicable
—
Consensus Value
$34.62
Model Assumptions
Discount Rate
10.3%
Growth Rate
14.8%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
A
84
Profitability
25/25
Strength
18/25
Valuation
22/25
Growth
19/25
Financial Health Signals
Strong profitability — ROE of 32% (above 20% is excellent)
Key Financials
- EPS (TTM)
- $2.19
- EPS (Forward)
- $2.51
- Book Value
- $7.17
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 31.9%
- Debt/Equity
- —
- Revenue Growth
- 11.9%
- Earnings Growth
- 14.8%
- Dividend Yield
- N/A
- Beta
- 0.86
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance